[ET Net News Agency, 12 August 2021] WUXI BIO (02269) fell 5.26% to HK$117, dipping
below the 100-D SMA of HK$117.5.
It hits an intra-day low of HK$117, and an intra-day high of HK$126.5. The total shares
traded was 6.29 million, with a value of HK$765.74m. The active buy/sell ratio is 49:51,
with net selling turnover of HK$14.83m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$42.08m, with volume weighted average price of HK$121.472.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$64.19m, with
volume weighted average price of HK$119.931. The stock has fallen a combined 8.24% over
the past 2 consecutive trading days.
The Hang Seng Index now fell 76 points, or 0.29% to 26,583; the Hang Seng China
Enterprises Index now fell 32 points, or 0.34% to 9,515; the Hang Seng TECH Index now fell
30 points, or 0.45% to 6,790; with an overall turnover of HK$35.03b.
The SSE Composite Index now rose 3 points, or 0.1% to 3,536, with an overall turnover of
RMB189.44b.
The SZSE Component Index now fell 4 points, or 0.03% to 15,016, with an overall turnover
of RMB128.86b.
Basic Information
-------------------------------------------
Nominal 117.000 % Chg -5.26%
High 126.500 Low 117.000
Shares Tr 6.29m Turnover 765.74m
10-D SMA 124.390 %H.V 74.346
20-D SMA 126.265 VWAP 121.651
50-D SMA 129.148 RSI14 42.115
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 49:51, with net selling
turnover of HK$14.83m, falling a combined 8.24% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 117.0 -5.26
HUTCHMED (00013) 64.3 -3.31
GENSCRIPT BIO (01548) 34.4 -3.10
INNOVENT BIO (01801) 72.4 -2.29
JXR (01951) 13.9 -1.14
BRII-B (02137) 37.5 -6.25
TIGERMED (03347) 138.5 -5.85
BEIGENE (06160) 161.8 -8.54
CANSINOBIO-B (06185) 315.0 -3.96
REMEGEN-B (09995) 121.0 -0.49
-------------------------------------------------
(ed)